Synthesize Bio

About Synthesize Bio

Synthesize Bio is a company focused on generative AI for genomics, aiming to predict outcomes of gene expression experiments. Their mission is to accelerate drug development and precision medicine by providing AI-generated gene expression data and insights for clinical decision support, biomarker discovery, and trial optimization.

Products & Services

GEM-1:A generative AI model that accurately predicts real-world gene expression experiments.

Generative Genomics Engine:A platform to predict results of future or impossible gene expression experiments using generative AI models.

Clinical Decision Support:AI-enriched metadata and expression profiles to support biomarker-driven clinical trial design and real-world evidence generation.

Clinical Biomarker Discovery:AI-generated gene expression data to accelerate identification of predictive biomarkers for patient stratification and drug response.

Clinical Trial Optimization:AI-generated datasets to identify patient populations likely to respond to therapies, reducing trial failure rates.

Precision Medicine Insights:Harmonized expression data to support development of companion diagnostics and personalized treatment strategies.

Pharmacodynamic Modeling:Synthetic RNA-seq data for mechanism of action studies, dose-response modeling, and target engagement analysis.

Specialties

Generative AI for Genomics Gene Expression Data Synthesis Clinical Trial Design Biomarker Discovery Precision Medicine Pharmacodynamic Modeling Omics Data Analysis Therapeutic Response Prediction

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Seed T: - FT: Seed	A: 10000000 MR: - FA: $10 million FAN: 10000000	D: 2025-09-17 FD: 2025-09-17	5 investors

Seed Latest

2025-09-17

$10.0M

5 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

R

Rob Bradley

Co-CEO, Co-Founder

J

Jeff Leek

Co-CEO, Co-Founder

L

Liza Ray

Head of Operations

S

Stein Setvik

Head of Platform

A

Alice Walsh

Head of Data

A

Alex Abbas

Director of Computational Biology

View 13 more team members with Pro

Unlock Full Team Directory

Recent News

Synthesize Bio Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised